Ubs Group Ag Creative Medical Technology Holdings, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.35 - $5.17 $7,042 - $104,030
20,122 Added 186.63%
30,904 $11,000
Q3 2022

Nov 10, 2022
BUY
$0.55 - $5.07 $5,930 - $54,664
10,782 New
10,782 $5,000
Q2 2022

Aug 10, 2022
SELL
$0.62 - $3.66 $5,679 - $33,525
-9,160 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.33 - $4.54 $12,182 - $41,586
9,160 New
9,160 $36,000

About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ Quotes by TradingView
  • Ticker CELZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,070,300
  • Market Cap $32.5M
  • Description
  • Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for...
More about CELZ
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email